Abteilungen

Abteilung Allgemein- und Viszeralchirurgie

• Gaedcke J, Grade M, Jung K, Schirmer M, Jo P, Obermeyer C, Wolff HA, Herrmann MK, Beissbarth T, Becker H, Ried T, Ghadimi M (2010):
  KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy. RADIOTHER ONCOL, 94(1): 76-81.
  
• Spitzner M, Emons G, Kramer F, Gaedcke J, Rave-Fränk M, Scharf JG, Burfeind P, Becker H, Beissbarth T, Ghadimi BM, Ried T, Grade M (2010):
  A gene expression signature for chemoradiosensitivity of colorectal cancer cells. IN J RADIAT ONCOL, 78(4): 1184-92.
  
• Sprenger T, Rodel F, Beissbarth T, Conradi LC, Rothe H, Homayounfar K, Wolff HA, Ghadimi BM, Yildrim M, Becker H, Rodel C, Liersch T (2010):
  Failure of down-regulation of Survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival. CLIN CANCER RES, [Epub ahead of print] doi: 10.1158/1078-0432.CCR-10-2592.
  
• Camps J, Grade M, Nguyen QT, Hörmann P, Becker S, Hummon AB, Rodriguez V, Chandrasekharappa S, Chen Y, Difilippantonio MJ, Becker H, Ghadimi BM, Ried T (2008):
  Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. CANCER RES, 68(5): 1284-95.
  
• Garman KS, Acharya CR, Edelman E, Grade M, Gaedcke J, Sud S, Barry W, Diehl AM, Provenzale D, Ginsburg GS, Ghadimi BM, Ried T, Nevins JR, Mukherjee S, Hsu D, Potti A (2008):
  A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities. P NATL ACAD SCI USA, 105(49): 19432-7.